Clinical Trial

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2009-03-27; most recent amendment 2025-12-01.
Status change: Active, Not Recruiting → Recruiting 2020-07-09
Status change: Recruiting → Active, Not Recruiting 2020-04-15
Trial Details
NCT Number NCT00872495
Lead Sponsor Lahey Clinic
Conditions Urothelial Cancer, Cancer, Bladder Neoplasms, Urinary Bladder Cancer
Enrollment 500 participants
Start Date 2002-09
Primary Completion 2028-10 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2025-12-08